Cargando…

Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson’s Disease: A Pilot Study

CSF from unique groups of Parkinson’s disease (PD) patients was biochemically profiled to identify previously unreported metabolic pathways linked to PD pathogenesis, and novel biochemical biomarkers of the disease were characterized. Utilizing both (1)H NMR and DI-LC-MS/MS we quantitatively profile...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yilmaz, Ali, Ugur, Zafer, Ustun, Ilyas, Akyol, Sumeyya, Bahado-Singh, Ray O., Maddens, Michael, Aasly, Jan O., Graham, Stewart F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693941/ https://www.ncbi.nlm.nih.gov/pubmed/33142859 http://dx.doi.org/10.3390/cells9112394

Ejemplares similares

Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer’s Disease and Mild Cognitive Impairment: A Pilot Study
por: Yilmaz, Ali, et al.
Publicado: (2020)

The Biochemical Profile of Post-Mortem Brain from People Who Suffered from Epilepsy Reveals Novel Insights into the Etiopathogenesis of the Disease
por: Lalwani, Ashna M., et al.
Publicado: (2020)

Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
por: Akyol, Sumeyya, et al.
Publicado: (2021)

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy
por: Aasly, Jan O., et al.
Publicado: (2015)

Association of Metabolomic Biomarkers with Sleeve Gastrectomy Weight Loss Outcomes
por: Miller, Wendy M., et al.
Publicado: (2023)

Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s Disease
por: Graham, Stewart F., et al.
Publicado: (2018)

Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease
por: Warø, Bjørg Johanne, et al.
Publicado: (2017)

What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?
por: Loeffler, David A., et al.
Publicado: (2019)

Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease
por: Vishweswaraiah, Sangeetha, et al.
Publicado: (2022)

Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
por: Smith, G. A., et al.
Publicado: (2015)

Metabolomic Profiling in LRRK2-Related Parkinson's Disease
por: Johansen, Krisztina K., et al.
Publicado: (2009)

Metabolomic Profiling of Cerebral Palsy Brain Tissue Reveals Novel Central Biomarkers and Biochemical Pathways Associated with the Disease: A Pilot Study
por: Alpay Savasan, Zeynep, et al.
Publicado: (2019)

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
por: Majbour, Nour K., et al.
Publicado: (2020)

Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson’s Disease-Associated LRRK2 Gene Mutations
por: Loeffler, David A., et al.
Publicado: (2017)

Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s disease
por: Flinkman, Dani, et al.
Publicado: (2023)

Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
por: Aasly, Jan O.
Publicado: (2021)

Analysis of Nigerians with Apparently Sporadic Parkinson Disease for Mutations in LRRK2, PRKN and ATXN3
por: Okubadejo, Njideka, et al.
Publicado: (2008)

Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
por: Kim, Hongwon, et al.
Publicado: (2019)

Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
por: Wang, Shijie, et al.
Publicado: (2017)

15-Multifaceted impact of caffeic acid phenethyl ester (CAPE) in experimental myocardial injuries
por: Akyol, Sümeyya, et al.
Publicado: (2015)

Mitochondrial DNA Deletions Discriminate Affected from Unaffected LRRK2 Mutation Carriers
por: Ouzren, Nassima, et al.
Publicado: (2019)

Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population
por: Fang, Jie, et al.
Publicado: (2016)

Differences in MTHFR and LRRK2 variant’s association with sporadic Parkinson’s disease in Mexican Mestizos correlated to Native American ancestry
por: Romero-Gutiérrez, Elizabeth, et al.
Publicado: (2021)

Bone resorption, matrix metalloproteinases and caffeic acid phenethyl ester
por: Akyol, Sumeyya, et al.
Publicado: (2016)

LRRK2 and Parkinson's disease: from genetics to targeted therapy
por: Sosero, Yuri L., et al.
Publicado: (2023)

Mitochondrial Mechanisms of LRRK2 G2019S Penetrance
por: Delcambre, Sylvie, et al.
Publicado: (2020)

The consumption of propolis and royal jelly in preventing upper respiratory tract infections and as dietary supplementation in children
por: Yuksel, Sevda, et al.
Publicado: (2016)

Writers Are Common among Parkinson's Disease Patients: A Longitudinal Study
por: Aasly, Anna, et al.
Publicado: (2021)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Long-Term Outcomes of Genetic Parkinson’s Disease
por: Aasly, Jan O.
Publicado: (2020)

Sporadic Parkinsonism
por: Nicoletti, G
Publicado: (2010)

Evaluation of the Role of LRRK2 Gene in Parkinson’s Disease in an East Indian Cohort
por: Sadhukhan, Tamal, et al.
Publicado: (2012)

Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
por: Lai, Dongbing, et al.
Publicado: (2021)

Role of LRRK2 variant p.Gly2019Ser in patients with Parkinsonism
por: Sadhukhan, Dipanwita, et al.
Publicado: (2020)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

LRRK2 and the Endolysosomal System in Parkinson’s Disease
por: Erb, Madalynn L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uul37073qh8t7j53b73nol8uft